Increased plasma levels of 8-iso-PGF2α and IL-6 in an elderly population with depression

Psychiatry Research

Volumn 161, Issue 1, 2008, Pages 59-66

  Dimopoulos, Nikolaos ^a   Piperi, Christina ^a   Psarra, Vassiliki ^b   Lea, Robert W ^c   Kalofoutis, Anastasios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Psychiatric Hospital of Attika Dafni   (Greece)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

8 iso PGF2 ; Depression; Elderly; IL 6

Indexed keywords

8 ISO PROSTAGLANDIN F2ALPHA; INTERLEUKIN 6; PROSTAGLANDIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; QUESTIONNAIRE;

AGE FACTORS; AGED; DEPRESSIVE DISORDER; DINOPROST; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-8; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; REFERENCE VALUES; RISK FACTORS;

EID: 52149109924     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.07.019     Document Type: Article

References (38)

1. Banks W.A., Kastin A.J., and Broadwell R.D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2 (1995) 241-248
2. Chehne F., Oguogho A., Lupattelli G., Budinsky A.C., Palumbo B., and Sinzinger H. Increase of isoprostane 8-epi-PGF (2alpha) after restarting smoking. Prostaglandins, Leukotrienes, and Essential Fatty Acids 64 (2001) 307-310
3. Davi G., Alesandrini P., Mezzetti A., Minotti G., Bucciarelli T., Costantini F., Cipollone F., Bittolo B.G., Ciabattoni G., and Patrono C. In vivo formation of 8-epi-prostaglandin F2a is increased in hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology 17 (1997) 3230-3235
4. Davi G., Guagnano M.T., Ciabattoni G., Basili S., Falco A., Marinopiccoli M., Nutini M., Sensi S., and Patrono C. Platelet activation in obese women: role of inflammation and oxidant stress. The Journal of the American Medical Association 288 (2002) 2008-2014
5. Diagnostic and Statistical Manual of Mental Disorders TR. Depressive disorders. (4th ed.) (2003), American Psychiatric Association, Washington, DC 369-382
6. Forlenza M.J., and Miller G.E. Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression. Psychosomatic Medicine 68 (2006) 1-7
7. Hanisch U.K. Migroglia as a source and target of cytokines. Glia 40 (2002) 140-155
8. Hayley S., Poulter M.O., Merali Z., and Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135 (2005) 659-678
9. Illife S., Haines A., Gallivan S., Booroff S., Goldenberg E., and Morgan P. Assessment of elderly people in general practice. British Journal of General Practice 41 (1991) 9-15
10. Irie M., Miyata M., and Kasai H. Depression and possible cancer risk due to oxidative DNA damage. Journal of Psychiatric Research 39 (2005) 553-560
11. Kent S., Bluthe R.M., Kelley K.W., and Dantzer R. Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences 13 (1992) 24-28
12. Khanzode S.D., Dakhale G.N., Khanzode S.S., Saoji A., and Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Report 8 (2003) 365-370
13. Kronfol Z., and Remick D. Cytokines and the brain. Implications for clinical psychiatry. American Journal of Psychiatry 157 (2000) 683-694
14. Maes M. Major depression and activation of the inflammatory response system. Advances in Experimental Medicine and Biology 461 (1999) 25-46
15. Maes M., Bosmans E., Meltzer H.Y., Scharpe S., and Suy E. Interleukin-1β: a putative mediator of HPA axis hyperactivity in major depression?. American Journal of Psychiatry 150 (1993) 1189-1193
16. Maes M., Meltzer H., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., and Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6 receptor, soluble interleukin-2 receptor and transferrin receptor in major depression. Journal of Affective Disorders 34 (1995) 301-309
17. McGivney S.A., Mulvihill M.M., and Taylor B. Validating the GDS depression screen in the nursing home. Journal of the American Geriatrics Society 42 (1994) 490-492
18. Mehrabi M.R., Ekmeckioglu C., Tatzber F., Oguogho A., Ullrich R., Morgan A., Tamaddon F., Grimm M., Glogar H.D., and Sinzinger H. The isoprostane 8-epi-PGF2a is accumulated in coronary arteries isolated from patients with coronary heart disease. Cardiovascular Research 43 (1999) 492-499
19. Montorio I., and Izal M. The Geriatric Depression Scale: a review of its development and utility. International Psychogeriatrics 8 (1996) 103-112
20. Morrow J.D., Awad J.A., Kato T., Takahashi K., Badr K.F., Roberts L.J., and Burk R.F. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. The Journal of Clinical Investigation 90 (1992) 2502-2507
21. Müller N., and Ackenheil M. Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry 22 (1998) 1-33
22. Murphy P.G., Borthwick L.A., Altares M., Gauldie J., Kaplan D., and Richardson P.M. Reciprocal actions of interleukin-6 and brain derived neurotrophic factor on rat and mouse primary sensory neurons. The European Journal of Neuroscience 12 (2000) 1891-1899
23. O'Brien S.M., Scott L.V., and Dinan T.G. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Human Psychopharmacology 19 (2004) 397-403
24. Ohtaki H., Takaki A., Yin L., Dohi K., Nakamachi T., Matsunaga M., Horai R., Asano M., Iwakura Y., and Shioda S. Suppression of oxidative stress after transient focal ischemia in interleukin-1 knock out mice. Acta Neurochirurgica. Supplementum 86 (2003) 191-194
25. Olff M. Stress, depression and immunity: the role of defense and coping styles. Psychiatry Research 85 (1999) 7-15
26. α-induced oxidative DNA damage biomarker, 8-hydroxy-2′-deoxyguanosine, in L929 cells. Journal of Cellular Physiology 174 (1998) 27-34
27. Pratico D., Lawson J., and FitzGerald G.A. Cyclooxygenase dependent formation of the isoprostane, 8-eri prostaglandin F2 alpha. The Journal of Biological Chemistry 270 (1995) 9800-9808
28. Pratico D., Rokach J., Lawson J., and FitzGerald G.A. F2 isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chemistry and Physics of Lipids 128 (2004) 165-171
29. Raj A. Depression in the elderly. Tailoring medical therapy to their special needs. Postgraduate Medicine 115 (2004) 26-42
30. Rapp S., Walsh D.A., Parisi A., and Wallace C.E. Detecting depression in elderly medical inpatients. Journal of Consulting and Clinical Psychology 56 (1988) 509-513
31. Reilly M., Delanty N., Lawson J.A., and FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94 (1996) 19-25
32. Sable J., Dunn L.B., and Zisook S. Late-life depression. How to identify its symptoms and provide effective treatment. Geriatrics 57 (2002) 18-35
33. Sajatovic M., and Ramirez L. Geriatric Depression Scale (GDS). In: Sajatovic M., and Ramirez L. (Eds). Rating Scales in Mental Health (2003), Lexi-Comp Inc., Hudson Cleveland 405-406
34. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., and Kirchner H. Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatrica Scandinavica 94 (1996) 198-204
35. 2 platelet activating factor-acethylhydrolase. Atherosclerosis 3 (2002) S57-S68
36. Van Kooten F., Ciabattoni G., Patrono C., Dippel P.W., and Koudstaal P.J. Platelet activation and lipid peroxidation in patients with acute ischemic stroke. Stroke 28 (1997) 1557-1563
37. a-isoprostane levels are increased in Alzheimer's disease: evidence of increased oxidative stress in vivo. Alzheimer's Reports 2 (1999) 277-282
38. Zhang R., Brennan M.L., Shen Z., McPherson J.C., Schmidt D., Molenda C.E., and Hazen S.L. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. The Journal of Biological Chemistry 277 (2002) 46116-46122